Cortechs.ai | Cortechs.ai and StatRad partner to help patients with neurodegenerative disease

Cortechs.ai and StatRad partner to help patients with neurodegenerative disease

Strategic relationship between quantitative imaging leader and key teleradiology company provides physicians and hospitals with comprehensive volumetric MRI reports.

(SAN DIEGO) April 8, 2014 – Cortechs.ai, Inc. is pleased to announce a partnership agreement with StatRad, LLC, a leading provider of innovative teleradiology services, which will distribute NeuroQuant® to its hospital and clinic clients. RadConnect, a division of StatRad that provides a medical image sharing platform, will also incorporate NeuroQuant into its solution.

NeuroQuant is the only FDA-cleared medical device for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of magnetic resonance images.

“I look forward to providing our clients with NeuroQuant reports,” said Vishal Verma, MD, CEO of StatRad. “We are happy to be able to provide our customers’ referring physicians with quantitative brain volume information that they can use in their assessment of neurodegenerative disease – like Alzheimer’s, Epilepsy, and TBI.  Integration of NeuroQuant into StatRad will provide more streamlined capabilities for our clients.”

StatRad and RadConnect support hospital and clinic clients across the U.S. using FDA-cleared technology to read hundreds of thousands of exams. NeuroQuant reports will be made available to hospital radiologists and referring physicians for specific Brain MRI exams.

“We are pleased to partner with StatRad, an innovative and quality-driven company,” said Guri Stark, CEO of Cortechs.ai. “Working with StatRad and its clients will help us fulfill our mission to assist physicians in effectively diagnosing and treating serious neurological disorders.”

To learn more about CorTechs and NeuroQuant, please visit cortechs.ai.

To learn more about StatRad and RadConnect, please visit www.statrad.com and www.radconnect.com.

About Cortechs.ai, Inc.

CorTechs develops and markets cutting-edge brain imaging solutions used by neurologists and radiologists in hundreds of clinics and research centers around the world.  CorTechs’ flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice.  As the only FDA cleared medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant® brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician’s desktop or mobile device. This provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify atrophy of brain structures to help diagnose a variety of brain disorders, including conditions such as Alzheimer’s disease, epilepsy and traumatic brain injury.

About StatRad, LLC

StatRad has been supporting radiology groups through nighttime teleradiology support since 1996. The company’s proprietary internally-developed technology system was specifically built for teleradiology and provides customers with a customizable, user-friendly interface that helps radiology groups streamline processes, increase efficiencies and deliver measurable results. RadConnect, a division of StatRad, provides a medical image sharing platform and vendor neutral archive solution.

###

Media Contact
Contact: Travis Foegler
Phone: +1 (619) 450-9094
Email: Tfoegler@cortechs.ai

More Resources

12/18/2025

Reimbursement Essentials for Quantitative Imaging: Key Takeaways From Our Expert Webinar

Our reimbursement webinar walked through best practices for billing, coding, and securing payment for NeuroQuant and OnQ Prostate, helping inform providers.

12/15/2025

OnQ Prostate for Radiation Oncology

OnQ Prostate is at the forefront of advanced imaging to empower the delivery of true precision therapies.

12/10/2025

Reflections on RSNA 2025 and What We Learned at the Cortechs.ai Booth 

If there was one overall takeaway from RSNA 2025, it’s that clinicians are ready for tools that reduce manual work and make reporting more consistent.

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

12/09/2025

SNO 2025 Recap: Collaboration Driving Innovation in Neuro-Oncology

The 2025 Society for Neuro-Oncology meeting was more than a conference, it was a hub of collaboration and conversation among industry leaders and physicians.

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.
Scroll to Top